Searching susceptibility genes for antipsychotic-induced weight gain: is the 5-HT2C receptor gene a promising candidate?
Evaluation of: de Luca V, Mueller DJ, de Bartolomeis A, Kennedy JL: Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis. Int. J. Neuropsychopharmacol. (2007) (Epub ahead print) [1] . Weight gain is a major adverse effect of the second-generation antipsychotics that are widely prescribed in psychiatric practice. Given its variability among patients and indirect evidence of its heritability, antipsychotic-induced weight gain has become a major target of pharmacogenetic studies. The protective effect of the T allele of the 5-HT2C receptor gene -759C/T promoter polymorphism on antipsychotic-induced weight gain has been repeatedly reported in independent studies. However, negative results have also been obtained, especially in subjects treated with clozapine. Recently, de Luca and colleagues investigated the association between the 5-HT2C receptor gene -759C/T promoter polymorphism and antipsychotic-induced weight gain using a meta-analytical approach [1] . The pooled data of eight studies (total 588 subjects) showed a trend of association between the -759T allele and lower weight gain, with evidence of significant between-study heterogeneity. Publication bias and the influence of confounding variables, such as age, gender, ethnicity, clozapine-treated patient proportions, durations of observation and the effect of weight gain cutoff criteria on effect size, were also evaluated in their meta-analysis. To clarify the contribution of the 5-HT2C receptor gene to a complex trait such as antipsychotic-induced weight gain, a greater number of independent studies with larger sample size that carefully consider various confounding factors and gene-environment interactions are required.